Amneal Pharmaceuticals, Inc. (AMRX) › Shareholders' EquityAmneal Pharmaceuticals, Inc. (AMRX) — Shareholders' EquityAnnual figures by fiscal year, from SEC filings.2017: $02018: $504.75M2019: $232.01M2020: $303.27M2021: $360.34M2022: $298.42M2023: $19.78M2024: -$109.27M2025: -$70.79M-$70.79M2017Shareholders' Equity (USD)2025Fiscal YearShareholders' EquityChange YoY2025-$70.79M+35.2%2024-$109.27M-652.4%2023$19.78M-93.4%2022$298.42M-17.2%2021$360.34M+18.8%2020$303.27M+30.7%2019$232.01M-54.0%2018$504.75M—2017$0—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share